Company profile: ValGenesis
1.1 - Company Overview
Company description
- Provider of an enterprise validation life-cycle management system that electronically manages the entire validation life-cycle from start to end. Automates validation to reduce cycle time and cost by at least 40 - 50%, enhances compliance, improves consistency, and standardizes corporate validation.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ValGenesis
Activiomics
HQ: United Kingdom
Website
- Description: Provider of phosphoproteomics solutions for biomarker discovery, diagnostics development, and drug candidate identification and profiling, leveraging patented, novel mass spectrometry-based approaches.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Activiomics company profile →
Clinical Trial Connect
HQ: United States
Website
- Description: Provider of a platform for disease foundations and advocacy groups to connect community members with relevant clinical trials. Citeline Connect accelerates clinical trial enrollment by connecting sponsors, recruitment partners, patients, healthcare providers, and sites through educational content, engagement strategies, and a globally compliant data analytics platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Trial Connect company profile →
GQ Life Sciences
HQ: United States
Website
- Description: Provider of life science information and search solutions: GenomeQuest, a patent search tool for DNA, RNA, and protein sequences with comprehensive comparison algorithms and a large indexed sequence database; and LifeQuest, a life science patent search platform using ontologies to understand biological queries and deliver complete, relevant results without false positives from non-life science patents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GQ Life Sciences company profile →
Methuselah Health
HQ: United Kingdom
Website
- Description: Provider of drug discovery solutions for ageing-related diseases, studying proteome instability and offering ProQuant, a quantitative proteomics platform to analyze proteome stability and identify novel therapeutic targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Methuselah Health company profile →
ChemNavigator
HQ: United States
Website
- Description: Provider of tools and services for scientists to find and procure chemistry for drug discovery, supporting research organizations in the United States and internationally. Offers the ChemNavigator platform to identify and procure chemistry for drug discovery and agrochemical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChemNavigator company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ValGenesis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ValGenesis
2.2 - Growth funds investing in similar companies to ValGenesis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ValGenesis
4.2 - Public trading comparable groups for ValGenesis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →